Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular …
K Morland, C Gerges, J Elwing… - Pulmonary …, 2023 - Wiley Online Library
This manuscript on real‐world evidence (RWE) in pulmonary hypertension (PH)
incorporates the broad experience of members of the Pulmonary Vascular Research …
incorporates the broad experience of members of the Pulmonary Vascular Research …
[HTML][HTML] Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies
J Tsai, S Malik, SC Tjen-A-Looi - Life, 2024 - pmc.ncbi.nlm.nih.gov
Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased
pulmonary vascular resistance and remodeling, often precipitating right-sided heart …
pulmonary vascular resistance and remodeling, often precipitating right-sided heart …
Outcomes of patients with elevated pulmonary artery systolic pressure on echocardiography due to chronic lung diseases
Background Pulmonary hypertension is associated with increased mortality, and lung
diseases are the second most common cause of pulmonary hypertension. We aimed to …
diseases are the second most common cause of pulmonary hypertension. We aimed to …
[HTML][HTML] PULMOEAST: A Comprehensive Analysis of Pulmonary Hypertension in Eastern India
AK Singhi, SK Mohapatra, N Biswas… - Cureus, 2023 - ncbi.nlm.nih.gov
Background Pulmonary hypertension (PH) is a debilitating cardiovascular disorder
characterized by abnormally elevated blood pressure within the lungs. The diverse range of …
characterized by abnormally elevated blood pressure within the lungs. The diverse range of …
Burdens and trends of pulmonary arterial hypertension at global, regional, and national levels from 1990 to 2021 and prediction to 2040: findings from the Global …
L Li, Y Zhang, Y Chen, R Liu, Y Gao, J Zheng, L Xing… - 2024 - researchsquare.com
Objective To estimate burdens and trends of pulmonary arterial hypertension (PAH) globally,
in five sociodemographic index (SDI) regions, 204 countries and territories around the world …
in five sociodemographic index (SDI) regions, 204 countries and territories around the world …
Clinical characteristics and outcomes of Group 3 and Group 4 Pulmonary Hypertension
Methods: A retrospective chart review of adult patients hospitalized from June 2012 to May
2021. Patients with pulmonary artery systolic pressure (PASP)≥ 35 mmHg on TTE were …
2021. Patients with pulmonary artery systolic pressure (PASP)≥ 35 mmHg on TTE were …